I
Incannex Healthcare Inc. (IXHL)
NCM – Real Time Price. Currency in USD
3.24
-0.17 (-4.99%)
At close: Mar 27, 2026, 4:00 PM EDT
3.23
-0.02 (-0.46%)
After-hours: Mar 27, 2026, 7:59 PM EDT
Get all premium features to the best stock analysis tool
NCM – Real Time Price. Currency in USD
3.24
-0.17 (-4.99%)
At close: Mar 27, 2026, 4:00 PM EDT
3.23
-0.02 (-0.46%)
After-hours: Mar 27, 2026, 7:59 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 48.27 | 2.52 | 10 | |
| Quick ratio | 48.27 | 1.78 | 10 | |
| Debt to Equity | 0.00 | -0.80 | 10 | |
| Debt to Assets | 0.00 | 0.73 | 10 | |
| Interest coverage | N/A | -13.90 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | 12K | 86K | N/A |
| Gross Profit | N/A | -88K | -91K | -160K | -186K |
| Operating Income | -11M | -14M | -30M | -24M | -26M |
| Net Income | -11M | -13M | -18M | -47M | -48M |
| EBITDA | -11M | -14M | -30M | -24M | -26M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 90 | 5.5 |
| Next quarter | 0 | 96.23 | 5.5 |
| Current year | 713.95 | 97.04 | 10 |
| Next year | 5614.29 | 175 | 10 |
| Weighted average score | 7.8 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -1.77 | 0 | 49.25 | 5.5 |
| Y/Y | -99.99 | -10.63 | 93.94 | -10.25 | 3.3 |
| 3y average | 871.56 | -71.87 | -154.3 | -14.16 | 3.3 |
| 5y average | 542.01 | -82.47 | -154.3 | -43.89 | 3.3 |
| Weighted average score | 3.9 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $69.2M significantly exceed its total debt $163.0K, ensuring strong financial flexibility
Total current assets $74.7M exceed Total current liabilities $1.5M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (-0.8), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$4.7M limits the company's ability to reinvest or pay down debt